Exact Mass: 336.0168

Exact Mass Matches: 336.0168

Found 41 metabolites which its exact mass value is equals to given mass value 336.0168, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline

6-nitro-2,3-dioxo-1H,2H,3H,4H-benzo[f]quinoxaline-7-sulfonamide

C12H8N4O6S (336.0165)


D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D002491 - Central Nervous System Agents > D000927 - Anticonvulsants NBQX (FG9202) is a highly selective and competitive AMPA receptor antagonist. NBQX has neuroprotective and anticonvulsant activity[1].

   

[1S-[1a(Z),3a,4b]]-3-(3-Bromo-4-chloro-4-methylcyclohexyl)-4-oxo-2-pentenoic acid methyl ester

[1S-[1a(Z),3a,4b]]-3-(3-Bromo-4-chloro-4-methylcyclohexyl)-4-oxo-2-pentenoic acid methyl ester

C13H18BrClO3 (336.0128)


   
   

Octahydroxyanthraquinone

Octahydroxyanthraquinone

C14H8O10 (336.0117)


   

3-[2-Chloro-4-(5-nitrothiazol-2-ylazo)anilino]propiononitrile

3-[2-Chloro-4-(5-nitrothiazol-2-ylazo)anilino]propiononitrile

C12H9ClN6O2S (336.0196)


   

2-Bromo-9-phenyl-9H-fluoren-9-ol

2-Bromo-9-phenyl-9H-fluoren-9-ol

C19H13BrO (336.015)


   

3-BROMO-2-(3-METHOXYBENZYLOXY)PHENYLBO&

3-BROMO-2-(3-METHOXYBENZYLOXY)PHENYLBO&

C14H14BBrO4 (336.0168)


   

Disulfide,bis(4-methyl-2-nitrophenyl)

Disulfide,bis(4-methyl-2-nitrophenyl)

C14H12N2O4S2 (336.0238)


   

Cephalonium lactone

Cephalonium lactone

C14H12N2O4S2 (336.0238)


   

2-Bromo-N-(4-methoxybenzyl)-6-nitroaniline

2-Bromo-N-(4-methoxybenzyl)-6-nitroaniline

C14H13BrN2O3 (336.0109)


   

Nifurzide

5-nitro-N-[(E)-[(E)-3-(5-nitrofuran-2-yl)prop-2-enylidene]amino]thiophene-2-carboxamide

C12H8N4O6S (336.0165)


A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent

   

2-Bromo-N-(4-methoxybenzyl)-4-nitroaniline

2-Bromo-N-(4-methoxybenzyl)-4-nitroaniline

C14H13BrN2O3 (336.0109)


   

3-Bromo-N-(4-methoxybenzyl)-2-nitroaniline

3-Bromo-N-(4-methoxybenzyl)-2-nitroaniline

C14H13BrN2O3 (336.0109)


   

2,6-BIS-(4-CHLORO-PHENYL)-TETRAHYDRO-THIOPYRAN-4-ONE

2,6-BIS-(4-CHLORO-PHENYL)-TETRAHYDRO-THIOPYRAN-4-ONE

C17H14Cl2OS (336.0142)


   

4-Benzoyl-4-bromobiphenyl

4-Benzoyl-4-bromobiphenyl

C19H13BrO (336.015)


   

Recilisib

Recilisib

C16H13ClO4S (336.0223)


Recilisib (ON 01210) is a radioprotectant, which can activate AKT, PI3K activities in cells[1].

   

9-(3-bromophenyl)-9H-fluorene-9-ol

9-(3-bromophenyl)-9H-fluorene-9-ol

C19H13BrO (336.015)


   

Potassium bis(1,2-benzenediolato)(1,3-butadien-2-yl)silicate, min. 98

Potassium bis(1,2-benzenediolato)(1,3-butadien-2-yl)silicate, min. 98

C16H13KO4Si (336.022)


   

4-bromo-N-[(4-methoxyphenyl)methyl]-2-nitroaniline

4-bromo-N-[(4-methoxyphenyl)methyl]-2-nitroaniline

C14H13BrN2O3 (336.0109)


   

N-(3-Chloro-4-fluorophenyl)-7-fluoro-6-nitro-4-quinazolinamine

N-(3-Chloro-4-fluorophenyl)-7-fluoro-6-nitro-4-quinazolinamine

C14H7ClF2N4O2 (336.0226)


   

3,4,5,3,4,5-Hexahydroxydiphenate

3,4,5,3,4,5-Hexahydroxydiphenate

C14H8O10-2 (336.0117)


   

(E)-3-[1-(benzenesulfonyl)pyrrol-2-yl]-2-methylsulfonylprop-2-enenitrile

(E)-3-[1-(benzenesulfonyl)pyrrol-2-yl]-2-methylsulfonylprop-2-enenitrile

C14H12N2O4S2 (336.0238)


   

5-amino-1-(5-phosphonato-D-ribosyl)imidazole-4-carboxylate

5-amino-1-(5-phosphonato-D-ribosyl)imidazole-4-carboxylate

C9H11N3O9P-3 (336.0233)


   

5-carboxylatoamino-1-(5-O-phosphonato-D-ribosyl)imidazole(3-)

5-carboxylatoamino-1-(5-O-phosphonato-D-ribosyl)imidazole(3-)

C9H11N3O9P-3 (336.0233)


   

2-Methyl-1-cyclopropanecarboxylic acid (7-bromo-4-oxo-2-pyrido[1,2-a]pyrimidinyl)methyl ester

2-Methyl-1-cyclopropanecarboxylic acid (7-bromo-4-oxo-2-pyrido[1,2-a]pyrimidinyl)methyl ester

C14H13BrN2O3 (336.0109)


   

5-amino-1-(5-phosphonato-D-ribosyl)imidazole-4-carboxylate

5-amino-1-(5-phosphonato-D-ribosyl)imidazole-4-carboxylate

C9H11N3O9P (336.0233)


Trianion of 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid.

   

5-carboxylatoamino-1-(5-O-phosphonato-D-ribosyl)imidazole(3-)

5-carboxylatoamino-1-(5-O-phosphonato-D-ribosyl)imidazole(3-)

C9H11N3O9P (336.0233)


Trianion of 5-carboxyamino-1-(5-phospho-D-ribosyl)imidazole arising from deprotonation of phosphate and carbamic acid functions.

   

nbqx

2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline

C12H8N4O6S (336.0165)


D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D002491 - Central Nervous System Agents > D000927 - Anticonvulsants NBQX (FG9202) is a highly selective and competitive AMPA receptor antagonist. NBQX has neuroprotective and anticonvulsant activity[1].

   

6-nitro-2,3-dioxo-1,4-dihydrobenzo[f]quinoxaline-7-sulfonamide

6-nitro-2,3-dioxo-1,4-dihydrobenzo[f]quinoxaline-7-sulfonamide

C12H8N4O6S (336.0165)


   

(5r)-4-[(1s,3s,4s)-3-bromo-4-chloro-4-methylcyclohexyl]-5-methoxy-5-methylfuran-2-one

(5r)-4-[(1s,3s,4s)-3-bromo-4-chloro-4-methylcyclohexyl]-5-methoxy-5-methylfuran-2-one

C13H18BrClO3 (336.0128)


   

1,2,3,4,5,6,7,8-octahydro-9,10-dimethyl anthracene

NA

C14H8O10 (336.0117)


{"Ingredient_id": "HBIN000566","Ingredient_name": "1,2,3,4,5,6,7,8-octahydro-9,10-dimethyl anthracene","Alias": "NA","Ingredient_formula": "C14H8O10","Ingredient_Smile": "C12=C(C(=C(C(=C1O)O)O)O)C(=O)C3=C(C2=O)C(=C(C(=C3O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41326","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

methyl (2z)-3-[(1s,3s,4s)-3-bromo-4-chloro-4-methylcyclohexyl]-4-oxopent-2-enoate

methyl (2z)-3-[(1s,3s,4s)-3-bromo-4-chloro-4-methylcyclohexyl]-4-oxopent-2-enoate

C13H18BrClO3 (336.0128)


   

(5s)-4-[(1r,3r,4r)-3-bromo-4-chloro-4-methylcyclohexyl]-5-methoxy-5-methylfuran-2-one

(5s)-4-[(1r,3r,4r)-3-bromo-4-chloro-4-methylcyclohexyl]-5-methoxy-5-methylfuran-2-one

C13H18BrClO3 (336.0128)


   

4-(3-bromo-4-chloro-4-methylcyclohexyl)-5-methoxy-5-methylfuran-2-one

4-(3-bromo-4-chloro-4-methylcyclohexyl)-5-methoxy-5-methylfuran-2-one

C13H18BrClO3 (336.0128)


   

(5r)-4-(3-bromo-4-chloro-4-methylcyclohexyl)-5-methoxy-5-methylfuran-2-one

(5r)-4-(3-bromo-4-chloro-4-methylcyclohexyl)-5-methoxy-5-methylfuran-2-one

C13H18BrClO3 (336.0128)


   

methyl 3-(3-bromo-4-chloro-4-methylcyclohexyl)-4-oxopent-2-enoate

methyl 3-(3-bromo-4-chloro-4-methylcyclohexyl)-4-oxopent-2-enoate

C13H18BrClO3 (336.0128)


   

(5r)-4-[(1r,3r,4r)-3-bromo-4-chloro-4-methylcyclohexyl]-5-methoxy-5-methylfuran-2-one

(5r)-4-[(1r,3r,4r)-3-bromo-4-chloro-4-methylcyclohexyl]-5-methoxy-5-methylfuran-2-one

C13H18BrClO3 (336.0128)


   

5,13-dichloro-10-hydroxy-4-methyl-2-oxa-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,9,11,13-heptaene-7-carboximidic acid

5,13-dichloro-10-hydroxy-4-methyl-2-oxa-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,9,11,13-heptaene-7-carboximidic acid

C15H10Cl2N2O3 (336.0068)


   

(5s)-4-(3-bromo-4-chloro-4-methylcyclohexyl)-5-methoxy-5-methylfuran-2-one

(5s)-4-(3-bromo-4-chloro-4-methylcyclohexyl)-5-methoxy-5-methylfuran-2-one

C13H18BrClO3 (336.0128)


   

methyl (2z)-3-[(1r,3s,4s)-3-bromo-4-chloro-4-methylcyclohexyl]-4-oxopent-2-enoate

methyl (2z)-3-[(1r,3s,4s)-3-bromo-4-chloro-4-methylcyclohexyl]-4-oxopent-2-enoate

C13H18BrClO3 (336.0128)